✦ LIBER ✦

Phase II study of fotemustine-5 fulederfoline (FU-FOL) in metastatic colorectal carcinomas (CRC): Preliminary results

✍ Scribed by Fabri, M.C.; Rougier, Ph.; Sarkany, M.; Ducreux, M.; Kac, J.; Berille, J.; Droz, J.P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequential methotrexate(MTX) and 5-fluor

✍ Thimmappaya, Bayar; Weissman, Sherman M. 📂 Article 📅 1986 🏛 Elsevier Science ⚖ 132 KB

758 - CPT11 alternating with 5 fluoroura

✍ C. Barone; C. Pozzo; H. Starkhammar; E. Terzoli; C. Garufi; L. Dirix; Y. Humblet 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 399 KB

754 5-FU/FA IV bolus therapy vs weekly h

✍ H.J. Weh; M. Hoffknecht; P. Hölzer; D. Braumann; R. Hoffman; H.J. Gellermann; K. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Individual 5-FU dose adaptation in metas

✍ Marc Ychou; Jacqueline Duffour; Andrew Kramar; Charles Debrigode; Sophie Gourgou 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 236 KB

A phase II study of biweekly irinotecan

✍ Salvador, J.; Bernabe, R.; Bolaños, M.; Borrega, P.; Valladares, M.; Cobo, M.; R 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 371 KB

A phase-II trial of recombinant interleu

✍ Hamblin, T.J.; Inzani, V.; Sadullah, S.; Stevenson, F.K.; Williamson, P.; van de 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 310 KB